Drugs online research references









  • Altering clinical features of recurrent herpes simplex virus-induced keratitis.
  • Oral acyclovir prophylaxis of varicella after intimate contact.
  • Induction of interleukin-10 on activation of Epstein-Barr virus in EBV-infected B-cell lines.
  • Specific oncolytic activity of herpesvirus saimiri in pancreatic cancer cells.
  • Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo.
  • Life-threatening infections occurring more than 3 months after BMT. 18 UK Bone Marrow Transplant Teams.
  • Potential in vitro activity of Kutapressin against Epstein-Barr virus.
  • Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
  • The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes.
  • Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus type 1 in vitro and in vivo.
  • Transduction of a drug-sensitive toxic gene into human leukemia cell lines with a novel retroviral vector.
  • Opportunistic infection in AIDS.
  • Acyclovir and guinea-pig airway smooth muscle
  • Herpesvirus saimiri pathogenicity enhanced by thymidine kinase of herpes simplex virus.
  • Prognostic factors in patients with idiopathic facial paralysis (Bell's palsy): A prospective study.
  • Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis.
  • A phase I and II study of pentostatin (Nipent) with cyclophosphamide for previously treated patients with chronic lymphocytic leukemia.
  • Outbreak of varicella in a pediatric oncology unit.
  • Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease.
  • Determination and pharmacokinetics of acyclovir after ingestion of suspension form.
  • Testing of some pharmacological characteristics of the autochthonous product Acyclovir.
  • Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV.
  • Purification and photoaffinity labeling of herpes simplex virus type-1 thymidine kinase.
  • Intermediate term results of total lymphoid irradiation for the treatment of non-specific graft dysfunction after heart transplantation.
  • Characterization and in-vivo ocular absorption of liposome-encapsulated acyclovir.
  • Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation.
  • Neonatal varicella: a report of 26 cases.
  • An in vitro nucleoside analog screening method for cancer gene therapy.
  • Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
  • Similarity in the linear and non-linear oral absorption of drugs between human and rat.
  • In vivo and in vitro analysis of skin penetration enhancement based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum.
  • Aerobic bacterial and fungal infections in peripheral blood stem cell transplants.
  • Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
  • In vitro modified release of acyclovir from ethyl cellulose microspheres.
  • Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.
  • Evaluation of glutathione and ascorbic acid as suppressors of drug-induced lipid peroxidation.
  • Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis.
  • Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.
  • 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
  • Rx drugs
  • Neonatal herpes simplex virus infections.
  • Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression.
  • Experimental study on inhibitory effect of xiaochaihu decoction on duck hepatitis B virus
  • Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
  • Effects of analgesics on delayed postherpetic pain in mice.
  • Determination of acyclovir in maternal plasma, amniotic fluid, fetal and placental tissues by high-performance liquid chromatography.
  • Acyclovir, ganciclovir, and zidovudine transfer into rat milk.
  • Structural characterization of the closed conformation of mouse guanylate kinase.
  • Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs.
  • Comparison of ganciclovir- and immune globulin-containing regimens in preventing cytomegalovirus infection in patients with renal transplants.
  • Actipol in treating stromal herpetic keratitis
  • Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study.
  • Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients.
  • Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines.
  • Characterization of acyclovir susceptibility and genetic stability of varicella-zoster viruses isolated during acyclovir therapy.
  • The efficacy of antiviral antibiotic 17997 on treatment of HSV-1 infected guinea pig skin infection
  • Evaluation of antiviral activity of different origin compounds by flow cytometry.
  • Efficacy of herpes vaccine and acyclovir (ACV) in a rabbit model following intraocular inoculation of herpes simplex virus.
  • Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
  • Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration.
  • Promoter sequences required for reactivation of Epstein-Barr virus from latency.
  • CDC writes first guidelines for sexually transmitted diseases.
  • Hydrophilic interaction liquid chromatography/electrospray mass spectrometry determination of acyclovir in pregnant rat plasma and tissues.
  • STDs: flushing out the "hidden epidemic".
  • Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.
  • A herpesvirus-caused enzootic--Pacheco's parrot disease--in a psittacine collection
  • Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
  • A cell line that secretes inducibly a reporter protein for monitoring herpes simplex virus infection and drug susceptibility.
  • Evaluation of prodrugs ability to induce effective ablation of cells transduced with viral thymidine kinase gene.
  • Liquid chromatographic method for the determination of ganciclovir and/or acyclovir in human plasma using pulsed amperometric detection.
  • Synthesis and biological activity of strongly fluorescent tricyclic analogues of acyclovir and ganciclovir.
  • Use of a single monoclonal antibody to determine the susceptibilities of herpes simplex virus type 1 and type 2 clinical isolates to acyclovir.
  • Preliminary pharmacokinetic study of different preparations of acyclovir with beta-cyclodextrin.
  • Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution.
  • Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity.
  • Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
  • Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.
  • Bioequivalence study of generic acyclovir compared with the brand name acyclovir.
  • Prodrugs of purine and pyrimidine analogues for the intestinal di/tri-peptide transporter PepT1: affinity for hPepT1 in Caco-2 cells, drug release in aqueous media and in vitro metabolism.
  • The experimental study on competitive PCR for quantitation of herpesviruses
  • Mathematical modelling of preparation of acyclovir liposomes: reverse phase evaporation method.
  • Study on the Rheum palmatum volatile oil against HBV in cell culture in vitro
  • Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
  • Pharmacokinetics of intravenous acyclovir, zidovudine, and acyclovir-zidovudine in pregnant rats.
  • Acyclovir permeation through rat skin: mathematical modelling and in vitro experiments.
  • Herpes simplex virus type 1 can either suppress or enhance human immunodeficiency virus type 1 replication in CD4-positive T lymphocytes.
  • Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients.
  • Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.
  • Outcome of treatment with valacyclovir and prednisone in patients with Bell's palsy.
  • Guanosine analogues as anti-herpesvirus agents.
  • Search of antimicrobial activity of selected non-antibiotic drugs.
  • Identification of a human valacyclovirase: biphenyl hydrolase-like protein as valacyclovir hydrolase.
  • Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir.
  • Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
  • Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
  • Dosing adjustment of 10 antimicrobials for patients with renal impairment.
  • Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid.
  • Inverse gas chromatography: considerations about appropriate use for amorphous and crystalline powders.
  • Inhibition of growth of estrogen receptor positive and estrogen receptor negative breast cancer cells in culture by AA-etherA, a stable 2-5A derivative.
  • Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells.
  • Prevention of postherpetic neuralgia: does it exist?
  • In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia.
  • Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
  • Inhibitory effect of anti-pyretic and anti-inflammatory herbs on herpes simplex virus replication.
  • Herpes simplex encephalitis. A study of seven patients and their immunological response prior to routine acyclovir treatment.
  • Evaluation on reducing effect of eye drop on herpes simplex virus-I in vitro
  • Role of acyclovir gel in herpes simplex: clinical implications.
  • Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum.
  • Spread of varicella-zoster virus DNA to the environment from varicella patients who were treated with oral acyclovir.
  • Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice.
  • Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option.
  • Reduced efficacy of ganciclovir against porcine and baboon cytomegalovirus in pig-to-baboon xenotransplantation.
  • Suppression of EBV release from irradiated B lymphoblastoid cell-lines: superior activity of ganciclovir compared with acyclovir.
  • Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): Pd-catalysed synthesis of 5-aryl derivatives and their biological evaluation.
  • Characteristics and repercussion of varicella-zoster virus infection in cardiac transplant.
  • Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
  • Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.
  • Preparation of acyclovir liposome and study on its stability
  • Synthesis and characterisation of sulfated amphiphilic alpha-, beta- and gamma-cyclodextrins: application to the complexation of acyclovir.
  • In Process Citation
  • Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum.
  • Protection and therapy of experimental herpesvirus infections in mice with immunomodulating Propionibacterium avidum KP-40 and/or acyclovir.
  • Herpes simplex virus hepatitis 4 years after liver transplantation.
  • Severe varicella zoster pneumonia during the course of treatment with azathioprine for Crohn's disease
  • Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
  • Prescribing trends in infectious keratitis: a survey of New Zealand ophthalmologists.
  • Enhanced isolation of low frequency herpes simplex virus recombinants using green-fluorescent protein and FACS.
  • Comparative efficacy of antiviral drugs on human ocular fibroblasts.
  • Down-regulation of Na+ transporters and AQP2 is responsible for acyclovir-induced polyuria and hypophosphatemia.
  • Changing paradigms in dermatology: antivirals in dermatology.
  • Advances in epidemiology, diagnosis and treatment of genital herpes
  • A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity.
  • Viral folliculitis on the face.
  • Delivery of "suicide" thymidine kinase gene of herpes virus in the complex with cationic peptide into human hepatoma cells in vitro
  • Pulmonary nodules in lung transplant recipients: etiology and outcome.
  • Solution, solid state and biological characterization of ruthenium(III)-DMSO complexes with purine base derivatives.
  • Herpes simplex virus type 1 acute retinal necrosis two years after presumably herpetic meningoencephalitis
  • Herpes simplex virus pneumonia in a patient with ependymoma.
  • Oral Antivirals for the Acute Treatment of Recurrent Herpes Labialis.
  • Acute retinal necrosis: clinical presentation, treatment, and prognosis in a series of 22 patients
  • Methodological study on the determination of oxiracetam concentration in serum and urine by HPLC
  • Modulation of ricin toxicity in mice by biologically active substances.
  • Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients.
  • Pharmacokinetics of acyclovir in patients undergoing continuous venovenous hemodialysis.
  • Epstein-Barr virus infection of HIV-seropositive individuals is transiently suppressed by high-dose acyclovir treatment.
  • Differential contribution of herpes simplex virus type 1 gene products and cellular factors to the activation of human immunodeficiency virus type 1 provirus.
  • Ribonucleotide reductase: an important enzyme in the replication of herpes simplex virus type 1 and a target for antiviral chemotherapy.
  • Effect of antibody alone and combined with acyclovir on neonatal herpes simplex virus infection in guinea pigs.
  • Duck hepatitis B virus model for screening of antiviral agents from medicinal herbs.
  • Ocular manifestations of HIV infection.
  • Clinical pharmacokinetics of oral acyclovir in patients on continuous ambulatory peritoneal dialysis.
  • A retrospective study on the effectiveness of oral acyclovir to prevent herpes simplex recurrence in corneal grafts.
  • Varicella pneumonia in the adult: study of 22 cases
  • Varicella pneumonia in the adult. Study of 9 cases
  • The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
  • Bioadhesive microspheres for ophthalmic administration of acyclovir.
  • Penciclovir and pathogenesis phenotypes of drug-resistant Herpes simplex virus mutants.
  • Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
  • Epstein-Barr virus infection in Richter's transformation.
  • Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
  • Activity of the Keggin polyoxotungstate PM-19 against herpes simplex virus type 2 infection in immunosuppressed mice: role of peritoneal macrophage activation.
  • Risk factors for postherpetic neuralgia.
  • Rational management of posttransplant lymphoproliferative disorder in pediatric recipients.
  • Infectious complications of pentostatin therapy.
  • Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir.
  • Preparation of acyclovir-polybutylcyanoacrylate-nanoparticles by emulsion polymerization method
  • Evaluation of a novel lipid prodrug for intraocular drug delivery: effect of acyclovir diphosphate dimyristoylglycerol in a rabbit model with herpes simplex virus-1 retinitis.
  • DNA interactions of a novel platinum drug, cis-PtCl(NH3)2(N7-acyclovir)+.
  • A survey of corneal graft practice in the United Kingdom.
  • Progressive varicella presenting with pain and minimal skin involvement in children with acute lymphoblastic leukemia.
  • Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis.
  • The Pregnancy Registry program at Glaxo Wellcome Company.
  • The physicochemical properties, plasma enzymatic hydrolysis, and nasal absorption of acyclovir and its 2'-ester prodrugs.
  • Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
  • Nephrotoxicity of acyclovir and ganciclovir in rats: evaluation of glomerular hemodynamics.
  • Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents.
  • A rapid and reliable assay for testing acyclovir sensitivity of clinical herpes simplex virus isolates independent of virus dose and reading time.
  • Scintillation proximity radioimmunoassay for the measurement of acyclovir.
  • Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.
  • Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients.
  • Immunotherapy of acute and recurrent herpes simplex virus type 2 infection with an adjuvant-free form of recombinant glycoprotein D-interleukin-2 fusion protein.
  • Dissociation of EBV genome replication and host cell proliferation in anti-IgG-stimulated Akata cells.
  • Herpetic stromal disease: response to acyclovir/steroid therapy.
  • Cerebrospinal fluid retrieval in the conscious dog: a methods development study.
  • The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation
  • Identification of important residues within the putative nucleoside binding site of HSV-1 thymidine kinase by random sequence selection: analysis of selected mutants in vitro.
  • A sensitive assay system screening antiviral compounds against herpes simplex virus type 1 and type 2.
  • Zinc sulfate and heparin for local therapy of herpes. Antiherpetic drugs, not leading to selection of HSV variants
  • Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
  • Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
  • Acute retinal necrosis. Silicon oil tamponade in retinal detachment
  • Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis.
  • Resistance of herpes simplex virus to acyclovir: laboratory and clinical aspects
  • Oral recrudescent herpes simplex virus infection.
  • Estimation of skin target site acyclovir concentrations following controlled (trans)dermal drug delivery in topical and systemic treatment of cutaneous HSV-1 infections in hairless mice.
  • Inhibitory activity of soyasaponin II on virus replication in vitro.
  • Drug utilisation pattern in sexually transmitted diseases and its economic considerations--a prospective study.
  • A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant.
  • Interruption of prophylaxis for major opportunistic infections in HIV-infected patients receiving triple combination antiretroviral therapy.
  • The impact of active herpes simplex virus infection on human immunodeficiency virus load.
  • Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir.
  • In vitro susceptibility study of herpes simplex virus to acyclovir and foscarnet. Are routine susceptibility studies necessary?
  • Substituent--directed aralkylation and alkylation reactions of the tricyclic analogues of acyclovir and guanosine.
  • The use of acyclovir in suspected encephalitis.
  • Quantitative study on synergistic effect of radix astragali A6 and acyclovir against herpes simplex virus type I by polymerase chain reaction
  • Expression of a Tat-inducible herpes simplex virus-thymidine kinase gene protects acyclovir-treated CD4 cells from HIV-1 spread by conditional suicide and inhibition of reverse transcription.
  • A comparative analysis of the use of mycophenolate mofetil in pediatric vs. adult renal allograft recipients.
  • Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.
  • Long-term oral acyclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts.
  • Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model.
  • Varicella-zoster virus thymidine kinase. Characterization and substrate specificity.
  • Correlation of in vivo topical efficacies with in vitro predictions using acyclovir formulations in the treatment of cutaneous HSV-1 infections in hairless mice: an evaluation of the predictive value of the C* concept.
  • Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin.
  • Herpes lymphadenitis in association with chronic lymphocytic leukemia.
  • Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome.
  • Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir.
  • Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
  • Chronic effects of azidothymidine and acyclovir on pregnant rats.
  • Antiherpetic activities of acidic protein bound polysacchride isolated from Ganoderma lucidum alone and in combinations with acyclovir and vidarabine.
  • Homoacyclovir analogues of unnatural bases and their activity against hepatitis B virus.
  • Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
  • Broad-spectrum antiherpes activities of 4-hydroxyquinoline carboxamides, a novel class of herpesvirus polymerase inhibitors.
  • Rx drugs
  • Rapid determination of valaciclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elution.
  • Clinical manifestations of varicella-zoster virus infections in human immunodeficiency virus-infected children.
  • Inhibition of varicella-zoster virus replication by an inhibitor of protein myristoylation.
  • Primary infection with varicella-zoster virus in risk groups
  • Optic neuritis heralding varicella zoster virus retinitis in a patient with acquired immunodeficiency syndrome.
  • Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir.
  • Switching viral latency to viral lysis: a novel therapeutic approach for Epstein-Barr virus-associated neoplasia.
  • Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues.
  • Varicella-zoster virus
  • The utilization of surface free-energy parameters for the selection of a suitable binder in fluidized bed granulation.
  • Characterization of volume-activated chloride currents in endothelial cells from bovine pulmonary artery.
  • Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells.
  • Detection of herpes simplex virus (HSV) in the saliva from 1,000 oral surgery outpatients by the polymerase chain reaction (PCR) and virus isolation.
  • Detection of herpes simplex virus DNA in semen of men with genital HSV-2 infection.
  • Compatibility of aztreonam with selected drugs during simulated Y-site administration.
  • Herpes zoster--treatment with acyclovir
  • Treatment of zoster oticus with acyclovir. Report from general practice and a small hospital department
  • Complications of varicella zoster virus reactivation in HIV-infected homosexual men.
  • Bell's Palsy and Herpes Zoster Oticus.
  • AIDS and the gateway of the body.
  • Strains of ganciclovir-resistant cytomegalovirus
  • Unilateral hyperfusion in brain-perfusion SPECT predicts poor prognosis in acute encephalitis.
  • Chronic urticaria: a Canadian perspective on patterns and practical management strategies.
  • Cognitive impairment after acute encephalitis: comparison of herpes simplex and other aetiologies.
  • Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells.
  • Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome.
  • Purification and characterization of a rat liver enzyme that hydrolyzes valaciclovir, the L-valyl ester prodrug of acyclovir.
  • Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris.
  • Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS.
  • Herpes zoster in children.
  • Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
  • Co-infection of acyclovir-resistant and acyclovir-sensitive herpes simplex type 2 virus strains in BS-C-1 cells.
  • Varicella pneumonitis: clinical presentation and experience with acyclovir treatment in immunocompetent adults.
  • Mode of action of (1'S,2'R)-9-1',2'-bis(hydroxymethyl) cycloprop-1'-ylmethylguanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
  • Activities of various compounds against murine and primate polyomaviruses.
  • Induced expression of the conditionally cytotoxic herpes simplex virus thymidine kinase gene by means of a parvoviral regulatory circuit.
  • Visceral and neurological complications in Varicella infections of adults
  • Topical treatment of cutaneous herpes simplex virus-1 infection in mice with a specially formulated caffeine gel (Cafon).
  • Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice.
  • Characterization of rhesus cytomegalovirus genes associated with anti-viral susceptibility.
  • Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo.
  • Prevention of cytomegalovirus infection and disease after lung transplantation: results using a unique regimen employing delayed ganciclovir.
  • Comparative in-vivo genotoxicity of antiviral nucleoside analogues; penciclovir, acyclovir, ganciclovir and the xanthine analogue, caffeine, in the mouse bone marrow micronucleus assay.
  • Treatment of acyclovir-unresponsive cutaneous herpes simplex virus infection with topically applied SP-303.
  • Effect of BV-araU and acyclovir on varicella-zoster virus replication with various length and timing of drug exposure.
  • Survey of the management of genital herpes in general practice.
  • Genital Herpes: Treatment Guidelines.
  • Varicella pneumonia in healthy adults. Apropos of 6 cases
  • Treatment of experimental herpesvirus infection with nonsteroidal anti-inflammatory agents
  • Antiviral effect in human cytomegalovirus-infected cells, pharmacokinetics, and intravitreal toxicology in rabbits of acyclovir diphosphate dimyristoylglycerol.
  • Efficacy of traditional herbal medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo.
  • Acyclovir resistance in herpes simplex virus isolates from keratitis cases: an analysis from a developing country.
  • Survey of resistance of herpes simplex virus to acyclovir in northwest England.
  • Retroviral transfer of herpes simplex thymidine kinase gene into glioma cells causes targeting of gancyclovir cytotoxic effect.
  • European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
  • Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.
  • Clinical presentation of herpes zoster in a Singapore hospital.
  • Medication use patterns in HIV-positive patients.
  • Rapid, simple and sensitive high-performance liquid chromatographic method for detection and determination of acyclovir in human plasma and its use in bioavailability studies.
  • Intestinal absorption of acyclovir beta-glucoside: comparative study with acyclovir, guanosine, and kinetin beta-glucoside.
  • Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers.
  • A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement.
  • Pharmacomanipulation of HSV-1 induced chorioretinitis in mice.
  • Inhibitory effects of IFN-gamma and acyclovir on the glioblastoma cell cycle.
  • Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring.
  • Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada.
  • Varicella and varicella immunity in patients with lysinuric protein intolerance.
  • Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model.
  • Valacyclovir. New indication: for genital herpes, simpler administration.
  • Herpes simplex virus infection in burned patients: epidemiology of 11 cases.
  • Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue.
  • Effect of genetically determined host factors on the efficacy of vidarabine, acyclovir and 5-trifluorothymidine in herpes simplex virus type 1 infection.
  • Varicella-zoster virus infection in children with malignancy.
  • Acyclovir triphosphate inhibits the diagnostic polymerase chain reaction for cytomegalovirus.
  • Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis.
  • Tetrandrine potently inhibits herpes simplex virus type-1-induced keratitis in BALB/c mice.
  • Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action.
  • Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice.
  • Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells.
  • Lymphotropic herpesviruses in allogeneic bone marrow transplantation.
  • Upper extremity infections in patients with the human immunodeficiency virus.
  • Cyclosporine-drug interactions and the influence of patient age.
  • Role of serology in the diagnosis of herpes simplex encephalitis.
  • High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation.
  • Effect of recombinant human interferon alpha B/D (rHu-IFN-alpha B/D) in combination with acyclovir in experimental HSV-1 encephalitis.
  • Herpes simplex encephalitis in infants and children.
  • Varicella zoster infections in children with acute lymphoblastic leukemia.
  • Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy.
  • Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo.
  • Herpes simplex esophagitis after renal transplantation.
  • Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
  • Automated high-performance liquid chromatographic method for the determination of acyclovir in plasma.
  • Acyclovir treatment of skin lesions results in immune deviation in mice infected cutaneously with herpes simplex virus.
  • Lymphoproliferative disorders after organ transplantation in children.
  • Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2.
  • Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
  • Cytomegalovirus disease after heart transplantation: is acyclovir prophylaxis indicated?
  • Herpetic meningoencephalitis in the elderly. Apropos of 13 cases
  • A calorimetric study of 3d metal ions-acyclovir interactions. The 2-hydroxyethoxymethyl group of acyclovir mimics the role of ribose in deoxy-guanosine and guanosine promoting the coordination through N(7).
  • Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
  • Bile salt-fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs.
  • Cytokine mRNA in BALB/c mouse corneas infected with herpes simplex virus.
  • Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy.
  • In vitro evaluation of mutant HSV-1 thymidine kinases for suicide gene therapy.
  • Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation.
  • Activity of penciclovir against Epstein-Barr virus.
  • Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir.
  • Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella.
  • An experimental study of a new route for Acyclovir administration for anti-keratitis therapeutic treatment
  • Inhibitory effect of a nucleoside analog, acyclovir, on leukemia cells.
  • Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
  • Antiviral drugs from the nucleoside analog family block volume-activated chloride channels.
  • A statistical study of ocular complications of herpes zoster ophthalmicus and its prolongation factors
  • Flow cytometric evaluation of antiviral agents against human herpesvirus 6.
  • Acyclovir in the treatment of recurrent respiratory papillomatosis: a preliminary report.
  • A new retroviral vector for detecting mutations and chromosomal instability in mammalian cells.







    online pharmacies || Hair Million herbal formula for hair loss and hair growth || Tramadol || Antibiotics and prescription medications online literature || Antibiotics